Yorkville Health Care Opportunities Cl A (YAM600)
10.25
+0.05 (+0.49%)
CAD |
Jul 05 2022
Returns Chart
Key Stats
Customize
Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
---|---|---|---|
2.50% | 6.596M | 0.00% | 60.80% |
1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
512933.6 | -8.60% | Upgrade | Upgrade |
Basic Info
Investment Strategy | |
The Fund seeks long-term capital appreciation. This Fund seeks to provide investors with long term capital appreciation by investing primarily in a diversified portfolio of global equity securities of issuers in the health care sector. |
General | |
Security Type | Mutual Fund |
Oldest Share Symbol | YAM615 |
Equity Style | Large Cap/Blend |
Fixed Income Style | -- |
Broad Asset Class | -- |
Broad Category | Equity |
Category Name | Sector Equity |
Category Index | Morningstar Gbl Mkts GR CAD |
Prospectus Objective | -- |
Fund Owner Firm Name | Yorkville Asset Management Inc. |
Prospectus Benchmark Index | |
S&P Global 1200 Health Care TR CAD | 100.0% |
Broad Asset Class Benchmark Index | |
^SPTSX60TR | 100.0% |
Manager Tenure | |
Hussein Amad | 7.06 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
69
512933.6
-391.33M
Category Low
445.62M
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of June 30, 2022
Performance Versus Category
As of July 05, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of July 05, 2022.
Asset Allocation
Top 10 Holdings
Name | % Weight | Price | % Change |
---|---|---|---|
UnitedHealth Group Inc | 6.80% | 509.50 | 0.84% |
Johnson & Johnson | 4.52% | 178.38 | 0.13% |
Pfizer Inc | 3.97% | 52.36 | 1.39% |
Regeneron Pharmaceuticals Inc | 3.87% | 598.79 | 0.37% |
Intuitive Surgical Inc | 3.85% | 206.30 | -0.22% |
Zoetis Inc Class A | 3.50% | 175.47 | 0.70% |
Thermo Fisher Scientific Inc | 3.45% | 545.96 | 0.16% |
Amgen Inc | 3.04% | 247.07 | 0.14% |
Bristol-Myers Squibb Co | 3.02% | 76.67 | 0.93% |
Cerner Corp
|
2.71% | -- | -- |
Basic Info
Investment Strategy | |
The Fund seeks long-term capital appreciation. This Fund seeks to provide investors with long term capital appreciation by investing primarily in a diversified portfolio of global equity securities of issuers in the health care sector. |
General | |
Security Type | Mutual Fund |
Oldest Share Symbol | YAM615 |
Equity Style | Large Cap/Blend |
Fixed Income Style | -- |
Broad Asset Class | -- |
Broad Category | Equity |
Category Name | Sector Equity |
Category Index | Morningstar Gbl Mkts GR CAD |
Prospectus Objective | -- |
Fund Owner Firm Name | Yorkville Asset Management Inc. |
Prospectus Benchmark Index | |
S&P Global 1200 Health Care TR CAD | 100.0% |
Broad Asset Class Benchmark Index | |
^SPTSX60TR | 100.0% |
Manager Tenure | |
Hussein Amad | 7.06 yrs |
Fundamentals
General | |
Distribution Yield | Upgrade |
Dividend Yield TTM (7-5-22) | 0.00% |
30-Day SEC Yield | -- |
7-Day SEC Yield | -- |
Number of Holdings | Upgrade |
Stock | |
Weighted Average PE Ratio | 20.57 |
Weighted Average Price to Sales Ratio | Upgrade |
Weighted Average Price to Book Ratio | Upgrade |
Weighted Median ROE | Upgrade |
Weighted Median ROA | Upgrade |
Forecasted Dividend Yield | Upgrade |
Forecasted PE Ratio | Upgrade |
Forecasted Price to Sales Ratio | Upgrade |
Forecasted Price to Book Ratio | Upgrade |
As of May 31, 2022
Growth Estimates
Fund Details
Key Dates | |
Inception Date | 5/13/2015 |
Last Annual Report Date | 3/31/2022 |
Last Prospectus Date | -- |
Share Classes | |
YAM615 | Fee-based Advice |
Attributes | |
Enhanced Index Fund | No |
Index Fund | No |
Inverse Fund | No |
Leveraged Fund | No |
Fund of Funds | No |
Currency Hedged Fund | No |
Synthetic Replication Fund | No |
Has Dividend Investment Plan | No |
Socially Responsible Fund | No |